🇺🇸 FDA
Patent

US 10526294

Pyrrolobenzodiazepines and conjugates thereof

granted A61KA61K31/5517A61K47/59

Quick answer

US patent 10526294 (Pyrrolobenzodiazepines and conjugates thereof) held by Mersana Therapeutics, Inc. expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Mersana Therapeutics, Inc.
Grant date
Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/5517, A61K47/59, A61K47/62, A61K47/68035